H2O America Finalizes $550M Equity Offering Terms to Fund Quadvest Acquisition, Signaling Over 30% Dilution

summarizeSummary

H2O America is proceeding with a $550 million common stock offering, including forward sale agreements, to fund its Quadvest Acquisition, which will result in significant share dilution.

check_boxKey Events

• Substantial Equity Offering Launched

  H2O America is raising $550 million through a common stock offering, consisting of $150 million directly from the company and $400 million via forward sale agreements. Underwriters also have an option to purchase an additional $82.5 million in shares.

• Financing for Quadvest Acquisition

  The net proceeds from this offering, combined with up to $140 million in expected debt financing, are earmarked to fund the $540 million Quadvest Acquisition and associated costs. If the acquisition does not close, proceeds will be used for general corporate purposes.

• Significant Share Dilution Expected

  The offering is projected to issue approximately 10.2 million new shares, increasing the total outstanding shares from 33.6 million to 43.8 million. This represents a potential dilution of over 30% for existing shareholders.

• Offering Priced at Market

  The shares are offered at $53.79 per share, which was the closing price of H2O America's common stock on February 27, 2026. The forward sale agreements are expected to physically settle by March 2028, with the final price subject to adjustments.

auto_awesomeAnalysis

H2O America has filed a prospectus supplement detailing the terms of a substantial $550 million common stock offering, which includes $150 million directly from the company and $400 million through forward sale agreements. This offering, which also includes an underwriters' option for an additional $82.5 million, is primarily intended to finance the previously announced $540 million Quadvest Acquisition and related expenses, alongside up to $140 million in debt financing. The shares are priced at $53.79, aligning with the closing price on February 27, 2026. This capital raise is highly dilutive, potentially increasing outstanding shares by over 30% from 33.6 million to 43.8 million (or 35% with the option exercised). While the acquisition and general need for financing were noted in the recent 10-K, this filing provides the critical specific terms and pricing of the equity component, making it a material update for investors.